Editorial
doi: 10.1001/jama.2009.1215.
The risks and benefits of HPV vaccination
- PMID: 19690315
- DOI: 10.1001/jama.2009.1215
Item in Clipboard
Editorial
The risks and benefits of HPV vaccination
JAMA.
.
No abstract available
Comment in
-
Efficacy data and HPV vaccination studies.JAMA. 2009 Dec 23;302(24):2658-9; author reply 2659-60. doi: 10.1001/jama.2009.1882. JAMA. 2009. PMID: 20040548 No abstract available.
-
Efficacy data and HPV vaccination studies.JAMA. 2009 Dec 23;302(24):2659; author reply 2659-60. doi: 10.1001/jama.2009.1883. JAMA. 2009. PMID: 20040549 No abstract available.
Comment on
-
Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine.JAMA. 2009 Aug 19;302(7):750-7. doi: 10.1001/jama.2009.1201. JAMA. 2009. PMID: 19690307
-
Marketing HPV vaccine: implications for adolescent health and medical professionalism.JAMA. 2009 Aug 19;302(7):781-6. doi: 10.1001/jama.2009.1179. JAMA. 2009. PMID: 19690311
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
